U.S. flag

An official website of the United States government

NM_006009.4(TUBA1A):c.217A>G (p.Thr73Ala) AND Lissencephaly due to TUBA1A mutation

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 18, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000850184.1

Allele description [Variation Report for NM_006009.4(TUBA1A):c.217A>G (p.Thr73Ala)]

NM_006009.4(TUBA1A):c.217A>G (p.Thr73Ala)

Gene:
TUBA1A:tubulin alpha 1a [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q13.12
Genomic location:
Preferred name:
NM_006009.4(TUBA1A):c.217A>G (p.Thr73Ala)
HGVS:
  • NC_000012.12:g.49186620T>C
  • NG_008966.1:g.7459A>G
  • NM_001270399.2:c.217A>G
  • NM_001270400.2:c.112A>G
  • NM_006009.4:c.217A>GMANE SELECT
  • NP_001257328.1:p.Thr73Ala
  • NP_001257329.1:p.Thr38Ala
  • NP_006000.2:p.Thr73Ala
  • NC_000012.11:g.49580403T>C
Protein change:
T38A
Links:
dbSNP: rs1592260393
NCBI 1000 Genomes Browser:
rs1592260393
Molecular consequence:
  • NM_001270399.2:c.217A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001270400.2:c.112A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006009.4:c.217A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Lissencephaly due to TUBA1A mutation (LIS3)
Synonyms:
Lissencephaly 3
Identifiers:
MONDO: MONDO:0012703; MedGen: C4305153; Orphanet: 171680; OMIM: 611603

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000992381Johns Hopkins Genomics, Johns Hopkins University
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jun 18, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Johns Hopkins Genomics, Johns Hopkins University, SCV000992381.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This TUBA1A variant is absent from large population datasets and TUBA1A missense variation appears to be extremely uncommon in these populations (gnomAD expected number of missense variants: 260.7, observed number of missense variants: 7, Z=5.58). This variant has not been reported in the literature, to our knowledge. Of two bioinformatics tools queried, one predicts that the substitution would be damaging, while the second predicts that it would be tolerated. The threonine residue at this position is evolutionarily conserved across all higher order mammals and nearly all other species assessed. Due to the apparently de novo state of this variant, the absence of this missense change from healthy population sets, and correlation with the patients clinical presentation, c.217A>G is likely pathogenic in this patient.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 2, 2023